Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (51-60 of 219) with videos related to

Pageof 22
Sort By:
Science (New York, N.Y.)|July 28, 2016
Latency reversal and viral clearance to cure HIV-1David M Margolis, J Victor Garcia, Daria J Hazuda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 22, 2008
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170Daniel J Skiest, Amy Krambrink, Zhaohui Su, et al.
Cell Reports|October 4, 2018
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral LatencyTodd Bradley, Guido Ferrari, Barton F Haynes, et al.
AIDS (London, England)|May 29, 2004
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expressionLoyda Ylisastigui, Nancie M Archin, Ginger Lehrman, et al.
Nature Reviews. Microbiology|November 18, 2014
Eradicating HIV-1 infection: seeking to clear a persistent pathogenNancie M Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews. Microbiology|December 1, 2015
HIV reservoirs: what, where and how to target themMelissa J Churchill, Steven G Deeks, David M Margolis, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidNancie M Archin, Amy Espeseth, Daniel Parker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Words matter: Discussing research towards an HIV cure in research and clinical contextsJoseph D Tucker, Paul A Volberding, David M Margolis, et al.
Headache|December 17, 2002
Fatal ergotism induced by an HIV protease inhibitorMarc A Tribble, Clark R Gregg, David M Margolis, et al.
Journal of Virology|June 5, 2015
H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T CellsManoj K Tripathy, Mary E M McManamy, Brandon D Burch, et al.
Pageof 22

Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Science (New York, N.Y.)|July 28, 2016
Latency reversal and viral clearance to cure HIV-1David M Margolis, J Victor Garcia, Daria J Hazuda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 22, 2008
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170Daniel J Skiest, Amy Krambrink, Zhaohui Su, et al.
Cell Reports|October 4, 2018
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral LatencyTodd Bradley, Guido Ferrari, Barton F Haynes, et al.
AIDS (London, England)|May 29, 2004
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expressionLoyda Ylisastigui, Nancie M Archin, Ginger Lehrman, et al.
Nature Reviews. Microbiology|November 18, 2014
Eradicating HIV-1 infection: seeking to clear a persistent pathogenNancie M Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews. Microbiology|December 1, 2015
HIV reservoirs: what, where and how to target themMelissa J Churchill, Steven G Deeks, David M Margolis, et al.
AIDS Research and Human Retroviruses|February 26, 2009
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidNancie M Archin, Amy Espeseth, Daniel Parker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Words matter: Discussing research towards an HIV cure in research and clinical contextsJoseph D Tucker, Paul A Volberding, David M Margolis, et al.
Headache|December 17, 2002
Fatal ergotism induced by an HIV protease inhibitorMarc A Tribble, Clark R Gregg, David M Margolis, et al.
Journal of Virology|June 5, 2015
H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T CellsManoj K Tripathy, Mary E M McManamy, Brandon D Burch, et al.
Pageof 22